# Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor

> **NCT00724906** · PHASE3 · UNKNOWN · sponsor: **Alseres Pharmaceuticals, Inc** · enrollment: 240 (estimated)

## Conditions studied

- Parkinsonian Syndromes

## Interventions

- **DRUG:** 123 I - ALTROPANE®

## Key facts

- **NCT ID:** NCT00724906
- **Lead sponsor:** Alseres Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-07
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2010-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00724906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00724906, "Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00724906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*